Birk Möller,Lena-Luise Becker,Afshin Saffari,Alexandra Afenjar,Emanuele G Coci,Rachel Williamson,Catherine Ward-Melver,Marc Gibaud,Lucie Sedláčková,Petra Laššuthová,Zuzana Libá,Markéta Vlčková,Nancy William,Eric W Klee,Ralitza H Gavrilova,Jonathan Lévy,Yline Capri,Mena Scavina,Robert Walter Körner,Zaheer Valuvullah,Claudia Weiß,Greta Marit Möller,Moritz Thiel,Margje Sinnema,Erik-Jan Kamsteeg,Sandra Donkervoort,Veronique Duboc,Khaoula Zaafrane-Khachnaoui,Nour Elkhateeb,Laila Selim,Henri Margot,Victor Marin,Claire Beneteau,Bertrand Isidor,Benjamin Cogne,Boris Keren,Benno Küsters,Alan H Beggs,Casie A Genetti,Joost Nicolai,Jörg Dötsch,Anne Koy,Carsten G Bönnemann,Maja von der Hagen,Jürgen-Christoph von Kleist-Retzow,Nicol Voermans,Heinz Jungbluth,Hormos Salimi Dafsari

Abstract:Intracellular trafficking involves an intricate machinery of motor complexes including the dynein complex to shuttle cargo for autophagolysosomal degradation. Deficiency in dynein axonemal chains as well as cytoplasmic light and intermediate chains have been linked with ciliary dyskinesia and skeletal dysplasia. The cytoplasmic dynein 1 heavy chain protein (DYNC1H1) serves as a core complex for retrograde trafficking in neuronal axons. Dominant pathogenic variants in DYNC1H1 have been previously implicated in peripheral neuromuscular disorders (NMD) and neurodevelopmental disorders (NDD). As heavy-chain dynein is ubiquitously expressed, the apparent selectivity of heavy-chain dyneinopathy for motor neuronal phenotypes remains currently unaccounted for. Here, we aimed to evaluate the full DYNC1H1 -related clinical, molecular and imaging spectrum, including multisystem features and novel phenotypes presenting throughout life. We identified 47 cases from 43 families with pathogenic heterozygous variants in DYNC1H1 (aged 0-59 years) and collected phenotypic data via a comprehensive standardized survey and clinical follow-up appointments. Most patients presented with divergent and previously unrecognized neurological and multisystem features, leading to significant delays in genetic testing and establishing the correct diagnosis. Neurological phenotypes include novel autonomic features, previously rarely described behavioral disorders, movement disorders, and periventricular lesions. Sensory neuropathy was identified in nine patients (median age of onset 10.6 years), of which five were only diagnosed after the second decade of life, and three had a progressive age-dependent sensory neuropathy. Novel multisystem features included primary immunodeficiency, bilateral sensorineural hearing loss, organ anomalies, and skeletal manifestations, resembling the phenotypic spectrum of other dyneinopathies. We also identified an age-dependent biphasic disease course with developmental regression in the first decade and, following a period of stability, neurodegenerative progression after the second decade of life. Of note, we observed several cases in whom neurodegeneration appeared to be prompted by intercurrent systemic infections with double-stranded DNA viruses (Herpesviridae) or single-stranded RNA viruses (Ross-River fever, SARS-CoV-2). Moreover, the disease course appeared to be exacerbated by viral infections regardless of age and/or severity of NDD manifestations, indicating a role of dynein in anti-viral immunity and neuronal health. In summary, our findings expand the clinical, imaging, and molecular spectrum of pathogenic DYNC1H1 variants beyond motor neuropathy disorders and suggest a life-long continuum and age-related progression due to deficient intracellular trafficking. This study will facilitate early diagnosis and improve counselling and health surveillance of affected patients.

Exome Sequencing Identifies De Novo DYNC1H1 Mutations Associated with Distal Spinal Muscular Atrophy and Malformations of Cortical Development

Identification of LAMA2 Compound Heterozygous Variants: a Case Report

Missense mutation in DYNC1H1 gene caused psychomotor developmental delay and muscle weakness: A case report

Expanding the Phenotypic and Genetic Spectrum of Neuromuscular Diseases Caused by DYNC1H1 Mutations

Identification of a de novo DYNC1H1 mutation via WES according to published guidelines

Whole‐exome Sequencing Identified Two Novel Mutations of DYNC2LI1 in Fetal Skeletal Ciliopathy

Case report: Genotype and phenotype of <i>DYNC1H1</i>-related malformations of cortical development: a case report and literature review

Muscle and Bone Characteristics of a Chinese Family with Spinal Muscular Atrophy, Lower Extremity Predominant 1 (SMALED1) Caused by a Novel Missense DYNC1H1 Mutation

Patient-specific mutation of Dync1h1 in mice causes brain and behavioral deficits

Phenotypic and Genotypic Analysis of a Patient with Miyoshi Myopathy Caused by Truncated Protein.

The expanding clinical and genetic spectrum of DYNC1H1 -related disorders

Characterization of a novel deep-intronic variant in DYNC2H1 identified by whole-exome sequencing in a patient with a lethal form of a short-rib thoracic dysplasia type III

Compound heterozygous DYSF variants causing limb‐girdle muscular dystrophy type 2B in a Chinese family

Discovery of specific mutations in spinal muscular atrophy patients by next-generation sequencing

[Analysis of 4 children with DYNC1H1 gene related spinal muscular atrophy with lower extremity predominant 1].

Novel Partial Exon 51 Deletion in the Duchenne Muscular Dystrophy Gene Identified via Whole Exome Sequencing and Long-Read Whole-Genome Sequencing

A spontaneous missense mutation in the chromodomain helicase DNA-binding protein 8 (CHD8) gene: a novel association with congenital myasthenic syndrome

Targeted Next-Generation Sequencing Identifies Novel Compound Heterozygous Mutations of DYNC2H1 in a Fetus with Short Rib-Polydactyly Syndrome, Type III

De Novo Variants in the DYNC1H1 Gene Associated with Infantile Spasms

A De Novo Mutation in Dystrophin Causing Muscular Dystrophy in a Female Patient.

Identification of Two Novel Variants of the DMD Gene in Chinese Families with Duchenne Muscular Dystrophy